Malaysian Genomics Resource (0155) — Capital Reinvestment Ratio
Malaysian Genomics Resource (0155) has a Capital Reinvestment Ratio of 0.08x as of June 2026, meaning it reinvests 0% of its operating cash flow (RM1.01 Million) in capital expenditures (RM78.00K). Check tangible equity quality of Malaysian Genomics Resource to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Malaysian Genomics Resource Capital Reinvestment Ratio (2015–2026)
This chart tracks Malaysian Genomics Resource's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Malaysian Genomics Resource cash flow conversion.
Annual Capital Reinvestment Ratio for Malaysian Genomics Resource (2015–2026)
Year-by-year Capital Reinvestment Ratio for Malaysian Genomics Resource from 2015 to 2026. See Malaysian Genomics Resource (0155) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.06x | RM1.10 Million | RM71.64K | ▼ -99.7% |
| 2022 | 23.38x | RM56.92K | RM1.33 Million | ▲ +77574.7% |
| 2020 | 0.03x | RM11.67 Million | RM351.18K | ▼ -22.9% |
| 2017 | 0.04x | RM3.67 Million | RM143.49K | ▼ -20.7% |
| 2016 | 0.05x | RM3.68 Million | RM181.42K | ▼ -93.9% |
| 2015 | 0.80x | RM395.83K | RM318.34K | — |